Prise en charge thérapeutique de l'asthme de l'enfant : du consensus à la pratique

Aims for the management of asthma in children are to optimize quality of life and to maintain normal lung functions. International guidelines recommend rapid-acting inhaled β2-agonist as needed in children with intermittent asthma. Once asthma is persistent, mild, moderate or severe, daily long-term therapy with inhaled corticosteroids should be started. Association with long acting inhaled β2-agonist or leukotrien inhibitors are required in children not enough controlled with inhaled corticosteroids alone. Management of the asthmatic child should not be restricted to ant asthmatic drug prescription but should include patient and patient's family education as well as adequate health of life.